Isaac Health is a technology company.
Isaac Health has raised $16.0M across 2 funding rounds.
Isaac Health has raised $16.0M in total across 2 funding rounds.
Isaac Health has raised $16.0M in total across 2 funding rounds.
Isaac Health's investors include B Capital Group, Flare Capital Partners, Imaginary Ventures, Kaya Ventures, Meridian Street Capital, Primetime Partners, Trevor Fetter, Vineet Jain.
# Isaac Health: A Technology-Enabled Dementia Care Platform
Isaac Health is a virtual brain health and dementia care platform that uses technology and clinical expertise to address a critical gap in American healthcare.[2] Founded in 2022 by Dr. Julius Bruch (a former physician and medical researcher in neurodegenerative disease) and Dr. Joel Salinas (a neurologist specializing in behavioral neurology), the company delivers screening, diagnosis, treatment, and ongoing care management for dementia and other cognitive conditions.[2]
The platform serves multiple stakeholders: individual patients and caregivers seeking memory assessments, Medicare Advantage plans, health systems, senior living communities, and Accountable Care Organizations.[2][3] Isaac Health solves a fundamental problem in American healthcare—over 61% of dementia cases remain undiagnosed, and waiting times for the few available dementia specialists often exceed 6 months or even a year.[3][4] By combining virtual-first care delivery with predictive machine learning and clinical protocols developed by neurological specialists, Isaac Health makes specialist-level dementia care accessible within days rather than months, while reducing costs and improving outcomes.[3][6]
The company emerged from a clear clinical need. Dr. Bruch observed that while the pandemic accelerated telemedicine adoption, elderly patients—those most in need of quality healthcare—risked being left behind by technology.[1] The shortage of dementia specialists created a "dementia neurology desert" across most of the U.S., leaving millions of patients without timely access to care.[4] This insight drove Bruch and Salinas to launch Isaac Health in 2022 with the mission of making expert brain health care accessible, stigma-free, and delivered with dignity.[4]
The company achieved early traction quickly. By 2023, Isaac Health had attracted investment from B Capital and demonstrated impressive adoption among Medicare Advantage plans and Accountable Care Organizations.[3] The startup raised $5.7 million in seed funding and subsequently secured $10.5 million in additional capital, enabling expansion across multiple states.[2][7] As of the search results, Isaac Health operates in five states (New York, North Carolina, Florida, Georgia, and Colorado) with plans to expand to five additional states.[2]
Isaac Health operates at the intersection of three powerful healthcare trends. First, the aging population crisis—with millions of Americans at risk for dementia and specialist capacity severely constrained—creates urgent demand for scalable solutions.[4] Second, the post-pandemic normalization of telehealth has shifted patient and provider expectations, making virtual-first care models viable at scale.[1] Third, the rise of AI and predictive analytics in healthcare enables population health management that was previously impossible, allowing health systems and payers to identify at-risk patients proactively rather than reactively.[3]
The Centers for Medicare & Medicaid Services (CMS) has elevated dementia care as a major healthcare priority, creating favorable regulatory and reimbursement conditions for companies like Isaac Health.[2] This alignment between clinical need, technology capability, and policy support positions the company to capture significant market share in a fragmented, underserved sector.
Isaac Health is well-positioned to become the nation's platform for brain health, as its founders envision.[3] The company's expansion trajectory—from five states to ten within a year—suggests strong product-market fit and payer demand. Future growth will likely depend on deepening partnerships with major Medicare Advantage plans and health systems, expanding geographic reach, and potentially broadening the platform beyond dementia to other neurocognitive conditions.
The broader opportunity is substantial: if Isaac Health can successfully scale its model across the country, it could fundamentally reshape how dementia care is delivered—shifting from a specialist-dependent, access-constrained model to a distributed, technology-enabled system. This would represent a meaningful shift in how American healthcare addresses one of its most pressing challenges: caring for an aging population with cognitive decline.
Isaac Health has raised $16.0M across 2 funding rounds. Most recently, it raised $10.0M Series A in August 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2025 | $10.0M Series A | B Capital Group, Flare Capital Partners, Imaginary Ventures, Kaya Ventures, Meridian Street Capital, Primetime Partners, Trevor Fetter, Vineet Jain | |
| Jan 1, 2024 | $6.0M Seed | B Capital Group, Flare Capital Partners, Imaginary Ventures, Meridian Street Capital, Primetime Partners, Vineet Jain |